Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2009
03/26/2009WO2008154267A9 Dose profile measurement system for clinical proton fields
03/26/2009WO2008151319A3 Expression of soluble antibody fragment by truncation of ch1 domain
03/26/2009WO2008135467A3 Enhancement of seed oil / amino acid content by combinations of pyruvate kinase subunits
03/26/2009WO2008133536A3 New stem cell lines, their application and culture methods
03/26/2009WO2008054819A3 Cardiovascular stem cells, methods for stem cell isolation, and uses thereof
03/26/2009WO2008010101A8 Antagonist antibody against epha2 for the treatment of cancer
03/26/2009WO2007047341A3 Peroxisome proliferator-activator receptor delta (ppar delta) and the development of preimplantation embryos
03/26/2009WO2006014159A3 Methods of using regenerative cells in the treatment of musculoskeletal disorders
03/26/2009WO2005074359A3 Watermelon varieties having altered sugar ratios
03/26/2009WO2005014615A3 Self-assembling peptides incorporating modifications and methods of use thereof
03/26/2009WO2004094651A3 Novel human polypeptides encoded by polynucleotides
03/26/2009WO2004093804A3 Human polypeptides encoded by polynucleotides and methods of their use
03/26/2009WO2004064612A3 Regulation of tgf-b signaling by tomoregulin
03/26/2009US20090083883 D-Amino Acid Selection For Soybean
03/26/2009US20090083877 Transcription Factors, DNA and Methods for Introduction of Value-Added Seed Traits and Stress Tolerance
03/26/2009US20090083874 Production of proanthocyanidins to improve forage quality
03/26/2009US20090083869 Methods and compositions for identifying agents that inhibit an ns4b-mediated neoplastic cellular phenotype of hcv infected cells
03/26/2009US20090082717 Dermal micro-organs, methods and apparatuses for producing and using the same
03/26/2009US20090082548 System and method for production of antibodies in plant cell culture
03/26/2009US20090082425 Compounds from myrothecium sp. for inhibiting the growth of cancer cells
03/26/2009US20090082406 Cancer Therapy
03/26/2009US20090082379 Novel Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors
03/26/2009US20090082336 mGluR1 Antagonists as Therapeutic Agents
03/26/2009US20090082330 Certain substituted amides, method of making, and method of use thereof
03/26/2009US20090082317 Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3
03/26/2009US20090082299 Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells
03/26/2009US20090082298 Methods for producing microRNAs
03/26/2009US20090082289 Adenoviral vectors having a protein IX deletion
03/26/2009US20090082277 Potentiation of anticancer agents
03/26/2009US20090082274 Collections of repeat proteins comprising repeat modules
03/26/2009US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/26/2009US20090082264 123 Human Secreted Proteins
03/26/2009US20090082250 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
03/26/2009US20090081809 Monoclonal antibody specific to dentin-derived heparan sulfate
03/26/2009US20090081792 Immune potentiating compositions of cancer cells
03/26/2009US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids
03/26/2009US20090081790 Polynucleotide for Target Gene
03/26/2009US20090081789 Activation of nuclear factor kappa B
03/26/2009US20090081788 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
03/26/2009US20090081787 Agent for promoting hepatic cell replication and agent for improving insulin resistance
03/26/2009US20090081786 Peptide sequences for modulation of protein kinase C
03/26/2009US20090081785 Desiccated Biologics And Methods Of Preparing The Same
03/26/2009US20090081784 Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
03/26/2009US20090081783 Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytes
03/26/2009US20090081782 Methods for vitrification of human oocytes
03/26/2009US20090081781 Synthetic and standardized prion infectuous material, and uses thereof as an injecting inoculum
03/26/2009US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase
03/26/2009US20090081779 Tumor suppressor gene, p28ing5
03/26/2009US20090081760 Dmo methods and compositions
03/26/2009US20090081756 Nucleic acid-enzyme complex
03/26/2009US20090081752 Bioreactor, kit and method of using same
03/26/2009US20090081743 Transportable algae biodiesel system
03/26/2009US20090081734 Arabinitol Dehydrogenases from Neurospora crassa
03/26/2009US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR
03/26/2009US20090081727 CD33-Like Protein
03/26/2009US20090081725 Compositions of pamps and Listeria monocytogenes and methods of use
03/26/2009US20090081723 Bioreactor, cell culture method, and substance production method
03/26/2009US20090081705 Novel peptides and compositions which modulate apoptosis
03/26/2009US20090081692 Ceramide Kinase Loop
03/26/2009US20090081691 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins
03/26/2009US20090081689 Reagents and methods to enrich rare cells from body fluids
03/26/2009US20090081672 Testing by immunoassay for overexpression which is an indicator of breast cancer; relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. used in hybridization methods for the identification of chromosomal abnormalities
03/26/2009US20090081668 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
03/26/2009US20090081652 Constitutively Translocating Cell Line
03/26/2009US20090081642 Novel apoptosis gene EI24, compositions, and methods of use
03/26/2009US20090081354 Phytate Polynucleotides and Methods of Use
03/26/2009US20090081353 Corn plants and seed enhanced for asparagine and protein
03/26/2009US20090081331 Phytase
03/26/2009US20090081296 Extracorporeal cell-based therapeutic device and delivery system
03/26/2009US20090081280 Compositions and methods for modulating hemostasis
03/26/2009US20090081251 Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
03/26/2009US20090081246 Method for isolating hepatitis c virus peptides
03/26/2009US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
03/26/2009US20090081241 comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein
03/26/2009US20090081240 Human Anti-Kir Antibodies
03/26/2009US20090081238 Anti-notch1 NRR antibodies and methods using same
03/26/2009US20090081234 administering a composition comprising an effective amount of at least one isolated mammalian anti-tumor necrosis factor (TNF) antibody comprising at least one variable region comprising SEQ ID NO:7 and 8
03/26/2009US20090081230 Human cytomegalovirus neutralising antibodies and use thereof
03/26/2009US20090081228 Cyr61 compositions and methods
03/26/2009US20090081222 Novel splice variants of the egf receptor
03/26/2009US20090081218 Fusion proteins
03/26/2009US20090081215 Genetic products differentially expressed in tumors and use thereof
03/26/2009US20090081214 Genetic products differentially expressed in tumors and use thereof
03/26/2009US20090081210 Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells
03/26/2009US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
03/26/2009US20090081207 High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity
03/26/2009US20090081202 Immunogenic compositions and methods
03/26/2009US20090081196 Medicaments for fungal infections
03/26/2009US20090081195 Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility
03/26/2009US20090081189 Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells
03/26/2009US20090081185 Apoptotic agents
03/26/2009US20090081177 Methods and compositions for improving pregnancy outcome
03/26/2009US20090081175 Method for Treating Disseminated Cancer
03/26/2009US20090081172 Nucleic acid encoding a receptor other than an immunoglobulin, wherein the receptor binds to a MUC 1 tumor antigen independently of a major histocompatibility complex (MHC); activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor
03/26/2009US20090081170 Cardiac progenitor cells
03/26/2009US20090081169 Method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof
03/26/2009US20090081168 Method of forming a peptide-receptor complex with zsig33
03/26/2009US20090081157 Immunostimulatory Combinations for Vaccine Adjuvants
03/26/2009US20090081144 Cosmetic compositions
03/26/2009US20090081127 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
1 ... 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 ... 1827